Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Immunoflazid Pro is a herbal dietary supplement developed by the Ukrainian company Ecopharm. It is formulated as oral capsules containing Proteflazid, an ethanol extract derived from the wild grasses *Deschampsia caespitosa L.* and *Calamagrostis epigeios L.*, which is rich in biologically active substances such as carboxylic acids and flavonoids. The product is designed to support the normal functioning of the immune system by enhancing innate immunity and increasing the body's resistance to viral and bacterial infections. Its mechanism of action involves antioxidant, anti-inflammatory, and apoptosis-modulating effects, as well as the inhibition of viral enzymes such as DNA polymerase and thymidine kinase. It is indicated for adults and children aged 12 and older as supportive care during medical treatment for infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Immunoflazid Pro.